C07J 5/0007
Not substituted in position 17 alfa
Official title: {not substituted in position 17 alfa}
C07J5/0007 (Not substituted in position 17 alfa) appears on 92 US grants and 96 published applications in this corpus.
Search patents in C07J- Granted patents
- 92
- Published applications
- 96
- Assignees
- 59
- Inventors
- 187
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 5 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 1 | 6 |
| 2014 | 2 | 7 |
| 2015 | 2 | 6 |
| 2016 | 3 | 6 |
| 2017 | 5 | 9 |
| 2018 | 5 | 5 |
| 2019 | 9 | 6 |
| 2020 | 3 | 6 |
| 2021 | 2 | 12 |
| 2022 | 4 | 4 |
| 2023 | 6 | 8 |
| 2024 | 2 | 5 |
| 2025 | 3 | 6 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Dec 2025US 12,509,487 B2The Texas A&M University System
- Neuroactive steroids, compositions and uses thereof18 Nov 2025US 12,473,327 B2Sage Therapeutics, Inc.
- 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof21 Jan 2025US 12,201,640 B2Sage Therapeutics, Inc.
- Steroid derivative regulators, method for preparing the same, and uses thereof12 Nov 2024US 12,139,508 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Cocrystal of progesterone and preparation method and use thereof9 Jan 2024US 11,866,459 B2National Institutes for Food and Drug Control
- Non-hormonal steroid modulators of nf-kb for treatment of disease3 Sep 2026US 2026/0256810 A1ReveraGen BioPharma, Inc.
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Apr 2026US 2026/0116913 A1The Texas A&M University System
- Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same5 Feb 2026US 2026/0034146 A1Sage Therapeutics, Inc.
- 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof16 Oct 2025US 2025/0319106 A1Sage Therapeutics, Inc.
- Neuroactive steroids and compositions thereof7 Aug 2025US 2025/0250296 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series74US 5,939,545 ACoCensys, Inc. · 1999
- Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series70US 5,232,917 AUniversity of Southern California · 1993
- Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series62US 6,277,838 B1CoCensys, Inc. · 2001
- Chemical compounds60US 4,192,871 AGlaxo Laboratories Limited · 1980
- 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof59US 9,512,165 B2Sage Therapeutics, Inc. · 2016